ConductScience.org, home

Paper · 36010993

The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC.

Wang D and 5 others. Cancers (Basel), 2022. Cited by 68 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Papers, record 36010993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36010993

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
4.87
iCite
Revised in PubMed
2022-08-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang DDan
2Li YYuqiang
3Ge HHeming
4Ghadban TTarikhttps://orcid.org/0000-0002-1894-9893
5Reeh MMatthiashttps://orcid.org/0000-0001-9111-3905
6Güngör CCenaphttps://orcid.org/0000-0002-5173-9492

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References205

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,146,937Human lysyl oxidase-like 2.Bioorg Chem2014https://conductscience.org/library/papers/25146937PubMed
228,685,754Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.Nat Commun2017https://conductscience.org/library/papers/28685754PubMed
327,317,748Tumor-associated fibroblasts predominantly come from local and not circulating precursors.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27317748PubMed
426,390,428A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.Pancreas2016https://conductscience.org/library/papers/26390428PubMed
520,627,072Tumors as organs: complex tissues that interface with the entire organism.Dev Cell2010https://conductscience.org/library/papers/20627072PubMed
61,644,063Hyaluronan is a secretory product of human pancreatic adenocarcinoma cells.Eur J Cell Biol1992https://conductscience.org/library/papers/1644063PubMed
723,108,409Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.Oncogene2013https://conductscience.org/library/papers/23108409PubMed
831,063,753The Extracellular Matrix Modulates the Metastatic Journey.Dev Cell2019https://conductscience.org/library/papers/31063753PubMed
929,673,760Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.Matrix Biol2019https://conductscience.org/library/papers/29673760PubMed
1027,821,172A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma.J Hematol Oncol2016https://conductscience.org/library/papers/27821172PubMed

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42,979,040Naringenin in pancreatic cancer: emerging evidence on the tumor immune-stromal microenvironment, immunometabolic reprogramming, microbiota-host crosstalk, and therapeutic resistance.Front Immunol2026https://conductscience.org/library/papers/42979040PubMed
42,922,696Exploring the interaction between extracellular matrix components of bone marrow and prostate cancer cells in a novel 3D model.Res Sq2026https://conductscience.org/library/papers/42922696PubMed
42,512,419
Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications.
Cancers (Basel)2026https://conductscience.org/library/papers/42512419PubMed
42,364,974Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppression.Oncogenesis2026https://conductscience.org/library/papers/42364974PubMed
42,352,435MMPs' Impact on Carcinogenesis in Specific Organs and Systems.Cancers (Basel)2026https://conductscience.org/library/papers/42352435PubMed
42,073,517Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data.Cancers (Basel)2026https://conductscience.org/library/papers/42073517PubMed
42,055,627Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/42055627PubMed
41,799,699Dual-transferred atmospheric-pressure plasma jet modulates matrix metalloproteinase expression in breast cancer stem cells.Biochem Biophys Rep2026https://conductscience.org/library/papers/41799699PubMed
41,692,802Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance.Exp Hematol Oncol2026https://conductscience.org/library/papers/41692802PubMed
41,566,958Dynamic granular hydrogels to assess pancreatic cancer cell fate.Biomater Sci2026https://conductscience.org/library/papers/41566958PubMed

1 to 10 of 49

See all 49 cited by

Genes56

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36010993

GET https://conductscience.org/api/papers/v1/36010993/references?page=2